Skip to main content

Team Maureen

instagram

Head & Neck Cancer

FDA Expands Gardasil 9 Indication

The FDA has approved an expanded indication for Gardasil 9 for the prevention of oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58, according to Merck, the developer of the HPV 9-valent recombinant vaccine.1

Human trials of HPV cancer vaccine expected to begin by year's end

Researchers have advanced a cancer vaccine to human trials as part of pioneering research aimed at treating incurable HPV cancers of the head, neck, throat and tongue.

The research combines a newly developed Human Papillomavirus (HPV) vaccine with immunotherapy and is being spearheaded by Professor Ian Frazer and Brisbane's Princess Alexandra Hospital's Professor Sandro Porceddu.

"We are seeing an unprecedented rise in the incidence of HPV-associated oropharyngeal cancer (OPC) with the USA reporting a 225 per cent increase since the 1980s," Professor Porceddu said.

HPV-Oral Cancer Link Spotlights Health Disparities Among Men

An emerging new type of oral cancer in men has increased over the last 15 years. 1 The culprit is human papillomavirus (HPV), and key social factors are contributing to its growth. April is Oral Cancer Awareness Month, and with the ongoing rise in cases of throat cancer linked to HPV, 2 many medical and dental professionals are encouraging the public to take measures in an effort to help prevent this form of cancer.

ASCO Critiques Guideline for HPV Testing in Head and Neck Cancer

The College of American Pathologists created a guideline for the testing, application, interpretation, and reporting of human papillomavirus (HPV) in head and neck carcinomas. An ASCO Expert Panel recently reviewed the guideline and published their critique in the Journal of Clinical Oncology.1

Norm Coleman Advocates For HPV Vaccine Amid Cancer Battle

Former Minnesota Senator Norm Coleman is sharing a message of strength and awareness during his second battle with cancer.

“The cancer I have is caused by a virus,” Coleman said. “You can get a vaccination to prevent you from getting the HPV virus today.”

HPV Vaccine Gains Support of ADA

HPV Vaccine Gains Support of ADA
According to a resolution passed recently by the ADA House of Delegates, the ADA urges dentists to support the use and administration of the human papillomavirus virus vaccine, recognizing it as a way to help prevent infection of the types of HPV associated with oropharyngeal cancer.

Women With Head and Neck Cancer Receive Less Treatment and Have Inferior Outcomes Compared With Men

An analysis from the Kaiser Permanente Northern California cancer registry showed that women with head and neck cancer are less likely to receive intensive chemotherapy and have an inferior outcome compared with men.  

Women With Head and Neck Cancer Receive Less Treatment and Have Inferior Outcomes Compared With Men

An analysis from the Kaiser Permanente Northern California cancer registry showed that women with head and neck cancer are less likely to receive intensive chemotherapy and have an inferior outcome compared with men.

Florida man shares story of how he survived HPV cancer

Jason Mendelsohn was pondering a question during a financial exam in 2014 when his fingers grazed his neck, making him notice a bump he hadn’t felt before.

Oral HPV Infections and the Role of the Dental Professional

Human papilloma virus (HPV) is the most common sexually transmitted infection in the United
States. More than 200 types of human papillomavirus (HPV) have been identified with only a
few of these having an oncogenic potential

The Man's Guide to HPV

Michael Douglas caught major flak for saying oral sex gave him throat cancer. But if you're laughing, it's time to grow up. Oral cancers caused by the sexually transmitted human papillomavirus (HPV) have skyrocketed 225 percent in the past 15 years, with men accounting for 75 percent of all cases...

HPV Cancers in Men Take Off

Now head and neck cancers associated with the virus are on the rise, leading some experts to recommend that a gender-neutral or male-centric approach might be more effective.

Treatment Deintensification for HPV-Associated Oropharynx Cancer

The recognition that a subset of oropharynx cancers arise because of transforming human papillomavirus (HPV) infection was followed by evidence that not only did these cancers have a different epidemiology from the historically more prevalent tobacco-associated head and neck cancers, but they also had strikingly different biology, natural history, treatment responsiveness, and prognosis.

Oral Human Papillomavirus (HPV) Infection Risk Increased by Three Daily Cigarettes

According to a new study published in the Journal of the American Medical Association, researchers at the Johns Hopkins Boomberg School of Public Health in Baltimore, Maryland, have found that cigarette smokers are more likely to be positive for human papillomavirus (HPV)-16 compared with non-smokers.

Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners

Oral HPV16 DNA is commonly detected among patients with HPV-OPC at diagnosis, but not among their partners. Partners of patients with HPV-OPC do not seem to have elevated oral HPV infection compared with the general population.